Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China
<h4>Objective</h4> To determine the cost effectiveness of molecular monitoring in patients with chronic myeloid leukemia in the chronic phase (CML-CP) compared to no molecular monitoring from a Chinese payer perspective. <h4>Methods</h4> Analyses were conducted using a semi-M...
Enregistré dans:
Auteurs principaux: | Vikalp Kumar Maheshwari, Cassandra Slader, Nidhi Dani, Christina Gkitzia, Quan Yuan, Tengbin Xiong, Yu Liu, Ricardo Viana |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9736bccd0e28441da05c8d7f160fa01a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China.
par: Vikalp Kumar Maheshwari, et autres
Publié: (2021) -
Navigating Challenges in Monitoring Chronic Myeloid Leukemia with Multiple BCR-ABL1 Transcripts
par: Brittany M. Smith, et autres
Publié: (2021) -
METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
par: O. V. Smirnova, et autres
Publié: (2014) -
Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review
par: Tan BK, et autres
Publié: (2021) -
Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
par: Radhakrishnan Ramchandren, et autres
Publié: (2009)